151 related articles for article (PubMed ID: 17185465)
1. Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential.
Araki H; Yoshinaga K; Boccuni P; Zhao Y; Hoffman R; Mahmud N
Blood; 2007 Apr; 109(8):3570-8. PubMed ID: 17185465
[TBL] [Abstract][Full Text] [Related]
2. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents.
Araki H; Mahmud N; Milhem M; Nunez R; Xu M; Beam CA; Hoffman R
Exp Hematol; 2006 Feb; 34(2):140-9. PubMed ID: 16459182
[TBL] [Abstract][Full Text] [Related]
3. Cord blood stem cell expansion is permissive to epigenetic regulation and environmental cues.
Araki H; Baluchamy S; Yoshinaga K; Petro B; Petiwala S; Parajuli R; Milhem M; Lavelle D; DeSimone J; Mahmud N
Exp Hematol; 2009 Sep; 37(9):1084-95. PubMed ID: 19501128
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers.
Saraf S; Araki H; Petro B; Park Y; Taioli S; Yoshinaga KG; Koca E; Rondelli D; Mahmud N
Transfusion; 2015 Apr; 55(4):864-74. PubMed ID: 25363624
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells.
Mahmud N; Petro B; Baluchamy S; Li X; Taioli S; Lavelle D; Quigley JG; Suphangul M; Araki H
Biol Blood Marrow Transplant; 2014 Apr; 20(4):480-9. PubMed ID: 24374212
[TBL] [Abstract][Full Text] [Related]
6. Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells.
Wang X; Zhang W; Tripodi J; Lu M; Xu M; Najfeld V; Li Y; Hoffman R
Blood; 2010 Dec; 116(26):5972-82. PubMed ID: 20858855
[TBL] [Abstract][Full Text] [Related]
7. Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A.
Milhem M; Mahmud N; Lavelle D; Araki H; DeSimone J; Saunthararajah Y; Hoffman R
Blood; 2004 Jun; 103(11):4102-10. PubMed ID: 14976039
[TBL] [Abstract][Full Text] [Related]
8. Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis.
Shi J; Zhao Y; Ishii T; Hu W; Sozer S; Zhang W; Bruno E; Lindgren V; Xu M; Hoffman R
Cancer Res; 2007 Jul; 67(13):6417-24. PubMed ID: 17616702
[TBL] [Abstract][Full Text] [Related]
9. Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents.
Wang X; Zhang W; Ishii T; Sozer S; Wang J; Xu M; Hoffman R
Cancer Res; 2009 Oct; 69(19):7612-8. PubMed ID: 19752087
[TBL] [Abstract][Full Text] [Related]
10. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.
Young JC; Lin K; Hansteen G; Travis M; Murray LJ; Jaing L; Scollay R; Hill BL
Exp Hematol; 1999 Jun; 27(6):994-1003. PubMed ID: 10378888
[TBL] [Abstract][Full Text] [Related]
11. Chromatin-Modifying Agent-Expanded Human Cord Blood Cells Display Reduced Allostimulatory Capacity.
Petro B; Mahmud D; Taioli S; Ganapathy A; Senyuk V; Yoshinaga KG; Suphangul M; Rondelli D; Mahmud N
J Immunol; 2019 Apr; 202(8):2493-2501. PubMed ID: 30842275
[TBL] [Abstract][Full Text] [Related]
12. Role of epigenetic reprogramming in hematopoietic stem cell function.
Iancu-Rubin C; Hoffman R
Curr Opin Hematol; 2015 Jul; 22(4):279-85. PubMed ID: 26049747
[TBL] [Abstract][Full Text] [Related]
13. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.
Danet GH; Lee HW; Luongo JL; Simon MC; Bonnet DA
Exp Hematol; 2001 Dec; 29(12):1465-73. PubMed ID: 11750106
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.
Chen BP; Fraser C; Reading C; Murray L; Uchida N; Galy A; Sasaki D; Tricot G; Jagannath S; Barlogie B
Leukemia; 1995 Oct; 9 Suppl 1():S17-25. PubMed ID: 7475307
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of ex vivo expanded CD34
Zhang Y; Shen B; Guan X; Qin M; Ren Z; Ma Y; Dai W; Ding X; Jiang Y
Stem Cell Res Ther; 2019 Jun; 10(1):173. PubMed ID: 31196160
[TBL] [Abstract][Full Text] [Related]
16. Co-culture of human CD34+ cells with mesenchymal stem cells increases the survival of CD34+ cells against the 5-aza-deoxycytidine- or trichostatin A-induced cell death.
Koh SH; Choi HS; Park ES; Kang HJ; Ahn HS; Shin HY
Biochem Biophys Res Commun; 2005 Apr; 329(3):1039-45. PubMed ID: 15752760
[TBL] [Abstract][Full Text] [Related]
17. Decitabine suspends human CD34+ cell differentiation and proliferation during lentiviral transduction.
Uchida N; Hsieh MM; Platner C; Saunthararajah Y; Tisdale JF
PLoS One; 2014; 9(8):e104022. PubMed ID: 25089909
[TBL] [Abstract][Full Text] [Related]
18. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells.
Yang L; Dybedal I; Bryder D; Nilsson L; Sitnicka E; Sasaki Y; Jacobsen SE
J Immunol; 2005 Jan; 174(2):752-7. PubMed ID: 15634895
[TBL] [Abstract][Full Text] [Related]
20. Human reconstituting hematopoietic stem cells up-regulate Fas expression upon active cell cycling but remain resistant to Fas-induced suppression.
Dybedal I; Yang L; Bryder D; Aastrand-Grundstrom I; Leandersson K; Jacobsen SE
Blood; 2003 Jul; 102(1):118-26. PubMed ID: 12637333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
